Tumour Volume as an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer - A Protocol for a Prospective Database.
Patients with locoregional non small cell lung cancer are registered on study after tumour
volumes are outlined by a radiologist and prior to the commencement of any treatment.
All patients must have recorded the volume of disease in the primary tumour (and of involved
nodes > 1 cm diameter) as measured from a CT scan performed according to a standard set of
Following registration patients are treated with Definitive radiotherapy with or without
chemotherapy. Follow-up will occur with the collection of a minimum amount of data every 12
months from the date of registration on study.
Quality Assurance procedures will be implemented with each site that participates in the
Observational Model: Cohort, Time Perspective: Prospective
Peter MacCallum Cancer Centre, Australia
Australia: Human Research Ethics Committee